Low Levels of HER2 Expression: New Ideas for Differentiated Strategies in the Choice of Treatment for Triple-Negative Breast Cancers. Вопр. онкол. 2023, 69 (1), 38-44. https://doi.org/10.37469/0507-3758-2023-69-1-38-44.